Bunkerhill ECG-EF vs Zio XT ECG Monitoring System
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if your primary goal is to rapidly screen large populations for early indicators of heart failure risk using existing or routine 12-lead ECG data. This tool is ideal for integrating into automated clinical workflows to identify patients with reduced left ventricular ejection fraction (LVEF) without requiring additional patient-specific monitoring hardware.
View Bunkerhill ECG-EF →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you require continuous, long-term cardiac monitoring for up to 14 days to detect and diagnose intermittent arrhythmias or correlate symptoms with cardiac events. This wearable biosensor is best suited for patients needing extended observation in an ambulatory setting, offering high compliance and detailed data for comprehensive arrhythmia analysis.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Contact sales for pricing details. | Contact for pricing |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFBunkerhill ECG-EF integrates seamlessly with existing EHRs and clinical archives, analyzing routine ECG data without requiring a separate graphical user interface, which offers high usability for clinicians by minimizing workflow disruption. In contrast, while Zio XT aims for patient comfort with its wearable design, real-world patient feedback indicates potential discomfort during application and wear, leading to a less consistently positive user experience for patients.
Clinical Value
Zio XT ECG Monitoring SystemZio XT provides superior clinical value by offering continuous cardiac monitoring for up to 14 days with a proven highest diagnostic yield, lowest retesting rates, and fastest time to clinical diagnosis for arrhythmias. While Bunkerhill ECG-EF offers valuable early screening for heart failure risk, Zio XT provides a more definitive and comprehensive diagnostic pathway for its specific use case.
Pricing & Value
Zio XT ECG Monitoring SystemZio XT offers greater transparency in its pricing, providing specific cost details for monitoring per patient in the UK and proposed Medicare rates in the US, along with CPT codes for reimbursement. Bunkerhill ECG-EF only states 'contact for pricing,' offering no public indication of its cost structure.
Enterprise Readiness
Bunkerhill ECG-EFBunkerhill ECG-EF demonstrates strong enterprise readiness through its deep integration with EHRs via the Carebricks platform, which automates comprehensive clinical workflows including referrals and prior authorizations. Furthermore, Bunkerhill Health has proactively secured a CMS reimbursement pathway for AI cardiovascular analysis, indicating robust support for large-scale adoption and operationalization within health systems.
Innovation
Bunkerhill ECG-EFBunkerhill ECG-EF leverages 'Generative AI for clinical reasoning and action' within its Carebricks platform, enabling health systems to build and scale their own AI-powered workflows across various clinical and operational domains. This platform approach to AI deployment represents a broader and potentially more transformative innovation in healthcare AI application compared to Zio XT's device-specific advancements.
Support & Docs
Zio XT ECG Monitoring SystemZio XT offers comprehensive and easily accessible support for both patients and providers, including 24/7 customer care, a dedicated patient app with instructional content, and publicly available detailed manuals and FAQs. Bunkerhill Health primarily provides general contact information without readily available detailed public support documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | Zio XT ECG Monitoring System |
|---|---|---|
| Product Name | Bunkerhill ECG-EF | Zio XT ECG Monitoring System |
| Company | BunkerHill Health | iRhythm Technologies |
| Primary Detection/Function | Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in early identification of patients at risk for heart failure. | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| ECG Data Source | Routine 12-lead electrocardiograms (ECGs) | Wearable, single-lead ECG biosensor |
| Monitoring Duration | Not specified | Up to 14 days of continuous cardiac monitoring. |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Bunkerhill ECG-EF or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.